Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
Expert Opinion on Biological Therapy|January 7, 2014
Kinase-inhibitor-insensitive cancer stem cells in chronic myeloid leukemiaAlessandro Morotti, Cristina Panuzzo, Carmen Fava, et al.
International Journal of Molecular Sciences|December 24, 2021
Prothrombotic Phenotype in COVID-19: Focus on PlateletsCristina Barale, Elena Melchionda, Alessandro Morotti, et al.
Pharmaceuticals (Basel, Switzerland)|March 6, 2021
Non-Coding RNAs: The "Dark Side Matter" of the CLL UniverseMarcello Francesco Lingua, Giovanna Carrà, Beatrice Maffeo, et al.
Oncogene|July 16, 2002
K252a inhibits the oncogenic properties of Met, the HGF receptorAlessandro Morotti, Silvia Mila, Paolo Accornero, et al.
Antioxidants (Basel, Switzerland)|August 26, 2023
Impact of Physical Exercise on Platelets: Focus on Its Effects in Metabolic Chronic DiseasesCristina Barale, Elena Melchionda, Giulia Tempesta, et al.
Molecular Cancer|February 20, 2018
Targeting few to help hundreds: JAK, MAPK and ROCK pathways as druggable targets in atypical chronic myeloid leukemiaStefania Rocca, Giovanna Carrà, Pietro Poggio, et al.
Blood Reviews|December 1, 2016
Modeling myeloproliferative neoplasms: From mutations to mouse models and back againAlessandro Morotti, Stefania Rocca, Giovanna Carrà, et al.
Frontiers in Cell and Developmental Biology|May 27, 2022
Shedding Light on NF-κB Functions in Cellular OrganellesGiovanna Carrà, Lidia Avalle, Laura Seclì, et al.
Cellular and Molecular Life Sciences : CMLS|April 24, 2020
P53 vs NF-κB: the role of nuclear factor-kappa B in the regulation of p53 activity and vice versaGiovanna Carrà, Marcello Francesco Lingua, Beatrice Maffeo, et al.
Expert Opinion on Emerging Drugs|April 1, 2015
Update on emerging treatments for chronic myeloid leukemiaCarmen Fava, Alessandro Morotti, Irene Dogliotti, et al.
Pageof 9